drugset / Trial / NCT03919578
Protectivity and Safety Following Recombinant Hepatitis B Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Protectivity and Safety Following Recombinant Hepatitis B Vaccine with different source of Hepatitis B bulk compared to Hepatitis B (Bio Farma) vaccine in Indonesian Population
Timeline
- Start
- 2019-09-11
- Primary completion
- 2020-01-30
- Completion
- 2020-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Recombinant Hepatitis B (Bio Farma) | Vaccine | 1 ml | — |
| Subject | recombinant hepatitis B vaccine | Vaccine | 1 ml | — |
Indications
No indication recorded.